STOCKHOLM, Sweden--(BUSINESS WIRE)--LinkMed’s (STO:LMED) portfolio company SACS Medical has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for sales of its systems in the U.S. ”FDA clearance is a stamp of quality that will facilitate us in our search for an industrial partner for SACS Medical,” says Ingemar Lagerlöf, CEO, LinkMed.
